-
Lilly, Biotech, NIH to Develop Covid-19 Antibodies
Drug maker Eli Lilly and Co., a biotechnology company, and an agency of NIH are collaborating on antibodies for novel coronavirus vaccines and therapies.
-
FDA Clears High-Volume Covid-19 Test
The Food and Drug Administration cleared for use in the U.S. a high-volume diagnostic for the novel coronavirus that can run on automated systems already in place.
-
Engineered Probiotic Maker Gains $2.3M Seed Funding
A developer of genetically-modified bacteria designed to work in the gut is raising $2.3 million more in seed funds to expand its product line.
-
Gates Funding Covid-19 Vaccine Delivery Device
A biotechnology company developing a vaccine for the Covid-19 virus received funding to scale up a delivery device for the vaccine when it’s available.
-
Start-Up Developing Marine Bio-Inspired Super Glue
A new enterprise is creating an strong binding adhesive inspired by mussels, derived from research in a university chemistry and materials science lab.
-
Engineered Viruses Deployed to Treat Gut Infections
Academic and industry researchers created gene-editing viruses that in lab cultures and mice killed bacteria causing often deadly intestinal infections.
-
Biotech Partners for A.I. Drug Discovery in $1B Deal
Two companies are collaborating on the use of artificial intelligence to find new drugs addressing a set of proteins that regulate immune-related functions, including inflammation.
-
Business-Foundation Alliance Funds Covid-19 Treatments
Two foundations and a credit card company are providing seed money for development and manufacture of treatments for the novel coronavirus or Covid-19 pandemic.
-
Network Funding Tech To Boost Ovarian Cancer Care
An alliance of cancer centers in the U.S. is supporting four projects developing technologies for improving care for patients with advanced ovarian cancer.
-
FDA Okays MRI with Epilepsy Brain Stimulation
A company making brain stimulation systems to treat epilepsy received regulatory clearance for MRI scans in people with its implanted devices.